Literature DB >> 2115526

Role of nuclear protein kinase C in the mitogenic response to platelet-derived growth factor.

A P Fields1, G Tyler, A S Kraft, W S May.   

Abstract

We have assessed the involvement of nuclear envelope protein phosphorylation in the mitogenic response to platelet-derived growth factor (PDGF) in NIH/3T3 fibroblasts. We find that stimulation of quiescent NIH/3T3 cells with PDGF or with the mitogenic protein kinase C (PKC) activators phorbol 12-myristate 13-acetate (PMA) or bryostatin 1 (bryo) leads to rapid, dose-dependent phosphorylation of several nuclear envelope polypeptides. The predominant nuclear envelope targets for mitogen-induced phosphorylation are immunologically identified as the nuclear envelope lamins. All three lamin species (A, B and C) are phosphorylated in response to PMA or bryo, while lamins A and C are preferentially phosphorylated in response to PDGF. Phosphopeptide mapping and phosphoamino acid analysis indicate that similar serine sites on the lamins are phosphorylated in response to PDGF, PMA and bryo. Both mitogenicity and lamina phosphorylation induced by these mitogens can be inhibited by the selective PKC inhibitor staurosporine at 2 nM. Treatment of quiescent NIH/3T3 cells with PDGF, PMA or bryo leads to rapid translocation of PKC to the nuclear envelope. These data indicate that rapid nuclear events, including translocation of cytosolic PKC to the nuclear membrane and lamina phosphorylation, may play a role in the transduction of the mitogenic signals of PDGF from the cytoplasm to the nucleus in NIH/3T3 fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115526     DOI: 10.1242/jcs.96.1.107

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  17 in total

1.  Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion.

Authors:  M Bredel; I F Pollack; J M Freund; J Rusnak; J S Lazo
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.

Authors:  I F Pollack; S Kawecki
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

3.  Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C beta I.

Authors:  P I Bastiaens; T M Jovin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Effects of dipalmitoylglycerol and fatty acids on membrane structure and protein kinase C activity.

Authors:  E M Goldberg; R Zidovetzki
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

Review 5.  Nuclear lipid metabolism in NEST: Nuclear Envelope Signal Transduction.

Authors:  D M Raben; M B Jarpe; K L Leach
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

6.  Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide.

Authors:  Michal Blass; Ilana Kronfeld; Gila Kazimirsky; Peter M Blumberg; Chaya Brodie
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Nuclear deformability constitutes a rate-limiting step during cell migration in 3-D environments.

Authors:  Patricia M Davidson; Celine Denais; Maya C Bakshi; Jan Lammerding
Journal:  Cell Mol Bioeng       Date:  2014-09-01       Impact factor: 2.321

Review 8.  Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.

Authors:  Nikhil G Thaker; Ian F Pollack
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

9.  Properties of protein kinase C associated with nuclear membranes.

Authors:  K Buchner; H Otto; R Hilbert; C Lindschau; H Haller; F Hucho
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

10.  Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.

Authors:  Ramars Amanchy; Jun Zhong; Rosa Hong; James H Kim; Marjan Gucek; Robert N Cole; Henrik Molina; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2009-07-10       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.